Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content ++ Neurofibromatosis, type 1 (NF1)Von Recklinghausen’s disease ++ 237.70 Neurofibromatosis unspecified 237.71 Neurofibromatosis type 1 von Recklinghausen’s disease237.72 Neurofibromatosis type 2 acoustic neurofibromatosis237.73 Schwannomatosis237.7 Neurofibromatosis237.79 Other neurofibromatosis ++ Q85.00 Neurofibromatosis, unspecifiedQ85.01 Neurofibromatosis, type 1Q85.02 Neurofibromatosis, type 2Q85.03 SchwannomatosisQ85.09 Other neurofibromatosis ++ 5E: Impaired Motor Function and Sensory Integrity Associated with Progressive Disorders of the Central Nervous System +++ Description ++ Group of neoplastic disorders resulting from an autosomal dominant genetic disorder or chromosomal mutationType 1 is the most common with hyperpigmentation spots (café-au-lait spots) present at birth, tumors of skin, and progressive decline of nerves, muscle, and bones due to defect of chromosome 17Type 2, acoustic neuromas, due to defect of chromosome 22 +++ Essentials of Diagnosis ++ At least 2 of the following needed for diagnosisAt least 7 café-au-lait spots less than 5 mm prior to puberty and more than 15 mm after pubertyMore than 2 neurofibromasOptic gliomaMore than 2 Lisch nodules (tumors on the iris)Freckling in axilla or inguinal areasBony lesionsImmediate family member with type 1 neurofibromatosisAcoustic neuromas (type 2) involve tumors on inner ear nerves, brain, skull, spinal cord; including schwannomas, gliomas, and meningiomas +++ General Considerations ++ Type 1 involves dermal and epidermal benign tumors that affect myelin (neurofibromas) of peripheral nerves that can erode bone or cause compression of the nerve including optic nerve gliomasAcoustic neuromas result in hearing and balance deficits, as well as difficulty swallowing, and problems with eye movements and speech +++ Demographics ++ Neurofibromatosis type 1 accounts for 95% of all cases1:3000 births250% risk in siblings340% of those affected develop complications3 +++ Signs and Symptoms ++ Café-au-lait spots (type 1)62% seizures340% cognitive impairment315% hypertension315% optic glioma3Skin tumorsLisch nodulesLarge headScoliosisStrabismus (crossed eyes)Amblyopia (lazy eye)Cranial nerve VIII tumors (type 2)SeizuresPrecocious pubertyDifficulty with balanceTinnitusVertigoPainNumbness, tingling, weakness of toes or fingersSpeech deficitsAttention deficit hyperactivity disorder (ADHD) +++ Functional Implications ++ DeafnessFalls due to balance deficitsPain resulting in decreased function +++ Possible Contributing Cause ++ Autosomal dominant genetic disorder or mutation of chromosome 17 (type 1) or chromosome 22 (type 2) +++ Differential Diagnoses2 ++ McCune-Albright syndromeNoonan syndromeLEOPARD syndromeBannayan-Riley-Ruvalcaba syndrome (BRRS) +++ Laboratory Tests ++ Genetic testingAmniocentesisChorionic villus sampling +++ Imaging ++ MRIX-rayPET scanCT scan +++ Medical Procedures ++ Surgical removal ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.